2-FDCK: DEA Move to Emergency-Schedule Ketamine Analog Draws Fire

2-FDCK: DEA Move to Emergency-Schedule Ketamine Analog Draws Fire

The United States Drug Enforcement Administration has announced its intent to place 2-fluorodeschloroketamine (2-FDCK)—a structural analog of the anesthetic and antidepressant ketamine—into Schedule I of the Controlled Substances Act, effectively banning it. The proposed rule, published in the Federal Register on January 20, would use the DEA’s “emergency scheduling” powers—a fast-track mechanism for substances claimed to pose an “imminent hazar…